5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.38▲ | 0.38▲ | 0.38▲ | 0.38▲ | 0.38▼ |
MA10 | 0.38▲ | 0.37▲ | 0.37▲ | 0.38▼ | 0.39▼ |
MA20 | 0.37▲ | 0.38▲ | 0.38▲ | 0.39▼ | 0.35▲ |
MA50 | 0.38▲ | 0.38▼ | 0.38▼ | 0.40▼ | 0.42▼ |
MA100 | 0.38▼ | 0.39▼ | 0.38▼ | 0.35▲ | 1.42▼ |
MA200 | 0.39▼ | 0.39▼ | 0.38▲ | 0.40▼ | 3.37▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.001▲ | 0.001▲ | -0.002▼ | 0.022▲ |
RSI | 52.258▲ | 50.939▲ | 50.293▲ | 46.653▼ | 45.662▼ |
STOCH | 59.935 | 58.849 | 66.908 | 51.405 | 39.230 |
WILL %R | -30.725 | -30.725 | -30.725 | -47.106 | -57.838 |
CCI | 54.999 | 54.462 | 54.663 | -32.411 | -11.051 |
CDL | $ATHA Doji Candlestick Pattern Detected | Set Alert |
Sunday, September 14, 2025 05:30 AM
These are the upcoming stock splits for the week of September 15 to September 19, based on TipRanks’ Stock Splits Calendar. A stock split may ...
|
Thursday, September 11, 2025 07:17 AM
Athira Pharma, Inc. ("Athira" or "Company") (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore ...
|
Thursday, September 11, 2025 06:32 AM
An update from Athira Pharma ( ($ATHA) ) is now available. On September 10, 2025, Athira Pharma announced a 10-for-1 reverse stock split of its ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/09/25 | 0.379 | 0.3791 | 0.379 | 0.379 | 144,389 |
16/09/25 | 0.375 | 0.3856 | 0.3581 | 0.3817 | 141,439 |
15/09/25 | 0.3589 | 0.3897 | 0.3547 | 0.3841 | 294,528 |
12/09/25 | 0.36 | 0.38 | 0.3538 | 0.36 | 700,022 |
11/09/25 | 0.359 | 0.399 | 0.3525 | 0.3821 | 587,187 |
10/09/25 | 0.3799 | 0.3936 | 0.3622 | 0.381 | 128,136 |
09/09/25 | 0.371 | 0.39 | 0.371 | 0.3841 | 113,596 |
08/09/25 | 0.3906 | 0.40 | 0.3626 | 0.385 | 157,327 |
05/09/25 | 0.381 | 0.40 | 0.381 | 0.3903 | 133,527 |
04/09/25 | 0.381 | 0.3922 | 0.3764 | 0.387 | 67,835 |
|
|
||||
|
|
||||
|
|